Hormonal disorders and acne severity in women aged 18–50: the role of PCOS and insulin resistance
DOI:
https://doi.org/10.20883/jofa.131Keywords:
acne, adult women, hormonal disorders, insulin resistance, polycystic ovary syndromeAbstract
Background. Acne in young and adult women is a chronic hormonal-metabolic dermatosis that significantly impairs self-esteem and quality of life, owing to its predominantly facial distribution.
Aim. To assess the relationship between selected endocrine disorders — polycystic ovary syndrome (PCOS), insulin resistance, hyperandrogenism, and thyroid disease — and acne severity in women aged 18–50, and to evaluate patients' subjective skin assessments and the outcomes of hormonal treatment.
Material and methods. One hundred women aged 18–50 with self-reported skin problems completed an original online questionnaire covering sociodemographic data, diagnosed endocrine disorders, acne characteristics, skin hydration and sebum secretion, and the perceived effect of hormonal treatment. Statistical analysis was performed using the chi-square test (p < 0.05).
Results. Hormonal disorders were identified in 63% of participants, most commonly PCOS and insulin resistance (21% each). Acne was reported by 79% of women; moderate-to-severe disease predominated in those with hyperandrogenism (91.7%), PCOS (78.3%), and insulin resistance (72%; χ² = 133.84; p = 0.0019). No significant association was found between hormonal disorders and skin hydration or sebum secretion. Women receiving hormonal treatment more frequently reported skin improvement than untreated women (50% vs. 27.4%; χ² = 14.64; p = 0.0055).
Conclusions. Acne in adult women is strongly linked to endocrine disturbances — particularly PCOS and insulin resistance — underscoring the need for hormonal-metabolic work-up in patients with moderate-to-severe disease and for a holistic therapeutic approach that addresses both systemic causes and psychosocial burden.
Downloads
References
Skroza N, Tolino E, Mambrin A, Zuber S, Balduzzi V, Marchesiello A, et al. Adult acne versus adolescent acne: a retrospective study of 1,167 patients. J Clin Aesthet Dermatol. 2018;11(1):21-25. PMID: 29410726; PMCID: PMC5788264.
Dréno B, Thiboutot D, Layton AM, Berson D, Perez M, Kang S. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015;29(6):1096-1106. doi: 10.1111/jdv.12757.
Sharma R, Dogra N, Arora M. Psychosocial impact of acne vulgaris on the quality of life among adolescents versus adults. Clin Med (Lond). 2023;23(Suppl 6):35. doi: 10.7861/clinmed.23-6-s35.
Ju Q, Tao T, Hu T, Karadağ AS, Al-Khuzaei S, Chen WC. Sex hormones and acne. Clin Dermatol. 2017;35(2):130-137. doi: 10.1016/j.clindermatol.2016.10.004.
Layton AM, Gupta G, Seukeran D, Maruthappu T, Gaillard S, Whitehouse H, et al. What's new after NICE acne guidelines. Dermatol Ther (Heidelb). 2024;14(10):2727-2738. doi: 10.1007/s13555-024-01275-0.
Morshed ASM, Noor T, Uddin Ahmed MA, Mili FS, Ikram S, Rahman M, et al. Understanding the impact of acne vulgaris and associated psychological distress on self-esteem and quality of life via regression modeling with CADI, DLQI, and WHOQoL. Sci Rep. 2023;13(1):21084. doi: 10.1038/s41598-023-48182-6.
Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, et al. Impact of facial and truncal acne on quality of life: a multi-country population-based survey. JAAD Int. 2021;3:102-110. doi: 10.1016/j.jdin.2021.03.002.
Szepietowska M, Stefaniak AA, Krajewski PK, Matusiak L. Females may have less severe acne, but they suffer more: a prospective cross-sectional study on psychosocial consequences in 104 consecutive Polish acne patients. J Clin Med. 2024;13(1):4. doi: 10.3390/jcm13010004.
Damoulaki E, Sioutis D, Georgiadi EP, Trakakis E, Mastorakos G, Katoulis A, et al. The association of glucose metabolism disorders and acne in women with polycystic ovary syndrome (PCOS). In Vivo. 2025;39(4):2219-2227. doi: 10.21873/invivo.14017.
Gratton R, Del Vecchio C, Zupin L, Crovella S. Unraveling the role of sex hormones on keratinocyte functions in human inflammatory skin diseases. Int J Mol Sci. 2022;23(6):3132. doi: 10.3390/ijms23063132.
Rao A, Douglas SC, Hall JM. Endocrine disrupting chemicals, hormone receptors, and acne vulgaris: a connecting hypothesis. Cells. 2021;10(6):1439. doi: 10.3390/cells10061439.
Del Rosso JQ, Kircik L. The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris. J Dermatolog Treat. 2024;35(1):2298878. doi: 10.1080/09546634.2023.2298878.
Condrò G, Guerini M, Castello M, Perugini P. Acne vulgaris, atopic dermatitis and rosacea: the role of the skin microbiota-a review. Biomedicines. 2022;10(10):2523. doi: 10.3390/biomedicines10102523.
Dréno B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21(Suppl 1):18-24. doi: 10.1007/s40257-020-00531-1.
Cavallo I, Sivori F, Truglio M, De Maio F, Lucantoni F, Cardinali G, et al. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. Sci Rep. 2022;12(1):21104. doi: 10.1038/s41598-022-25436-3.
Lephart ED, Naftolin F. Menopause and the skin: old favorites and new innovations in cosmeceuticals for estrogen-deficient skin. Dermatol Ther (Heidelb). 2021;11(1):53-69. doi: 10.1007/s13555-020-00468-7.
Wilkinson HN, Hardman MJ. The role of estrogen in cutaneous ageing and repair. Maturitas. 2017;103:60-64. doi: 10.1016/j.maturitas.2017.06.026.
Pondeljak N, Lugović-Mihić L. Stress-induced interaction of skin immune cells, hormones, and neurotransmitters. Clin Ther. 2020;42(5):757-770. doi: 10.1016/j.clinthera.2020.03.008.
Chałubek A, Faruga-Lewicka W, Kardas M. The role of stress, circadian rhythm and hormonal changes in acne tarda. Aesthet Cosmetol Med. 2022;11(4):131-136. doi: 10.52336/acm.2022.020.
Ambalal SM. Metabolic syndrome and skin: interactions and implications. Indian J Dermatol. 2022;67(2):138-145. doi: 10.4103/ijd.ijd_155_21.
Sadowska-Przytocka A, Gruszczyńska M, Ostałowska A, Antosik P, Czarnecka-Operacz M, Adamski Z, et al. Insulin resistance in the course of acne-literature review. Postepy Dermatol Alergol. 2022;39(2):231-238. doi: 10.5114/ada.2021.107101.
Faro B, Silva-Ferraz B, Faro A. Acne, self-esteem, and mental health: a scoping review. Psychol Health Med. 2026;31(1):50-68. doi: 10.1080/13548506.2025.2465655.
Gruszczyńska M, Sadowska-Przytocka A, Szybiak W, Więckowska B, Lacka K. Insulin resistance in patients with acne vulgaris. Biomedicines. 2023;11(8):2294. doi: 10.3390/biomedicines11082294.
Szefler L, Szybiak-Skora W, Sadowska-Przytocka A, Zaba R, Wieckowska B, Lacka K. Metformin therapy for acne vulgaris: a meta-analysis. Pharmaceuticals (Basel). 2024;17(6):728. doi: 10.3390/ph17060728.
Och A, Och M, Nowak R, Podgórska D, Podgórski R. Berberine, a herbal metabolite in the metabolic syndrome: the risk factors, course, and consequences of the disease. Molecules. 2022;27(4):1351. doi: 10.3390/molecules27041351.
Zeichner JA, Baldwin HE, Cook-Bolden FE, Eichenfield LF, Fallon-Friedlander S, Rodriguez DA. Emerging issues in adult female acne. J Clin Aesthet Dermatol. 2017;10(1):37-46. PMID: 28210380; PMCID: PMC5300732.
Smith CA, Gosnell E, Karatas TB, Deitelzweig C, Collins EMB, Yeung H. Hormonal therapies for acne: a comprehensive update for dermatologists. Dermatol Ther (Heidelb). 2025;15(1):45-59. doi: 10.1007/s13555-024-01324-8.
Borzyszkowska D, Niedzielska M, Kozłowski M, Brodowska A, Przepiera A, Malczyk-Matysiak K, et al. Evaluation of hormonal factors in acne vulgaris and the course of acne vulgaris treatment with contraceptive-based therapies in young adult women. Cells. 2022;11(24):4078. doi: 10.3390/cells11244078.
Tommasino N, Annunziata MC, Potestio L, Napolitano M. Efficacy and safety of hormonal therapies for acne: a narrative review. Clin Cosmet Investig Dermatol. 2025;18:3331-3337. doi: 10.2147/CCID.S574341.
Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. doi: 10.1016/j.jaad.2023.12.017.
Szymańska K, et al. The gut-skin axis: the role of intestinal microbiota in acne, psoriasis and atopic dermatitis: a narrative review. J Educ Health Sport. 2025;83. doi: 10.12775/JEHS.2025.83.66771.
Zhu S, Chen H, He B, Zhang Y, Li P, Kuang J. Gut microbiota dysbiosis in polycystic ovary syndrome: focus on diet, probiotics, and traditional Chinese medicine. Front Microbiol. 2025;16:1659783. doi: 10.3389/fmicb.2025.1659783.
Bal Bayazıtlı EC, Aksoy Saraç G, Uzdoğan A, Acar O, Karaman HB, Külhan A, et al. Association between altered gut microbiota and acne vulgaris: a comparative study of trimethylamine N-oxide levels in patients and healthy controls. Dermatol Pract Concept. 2025;15(4):5486. doi: 10.5826/dpc.1504a5486.
Damoulaki E, Sioutis D, Sarli V, Trakakis E, Mastorakos G, Katoulis A, et al. Polycystic ovary syndrome-associated acne: the interplay of hyperandrogenism, insulin resistance, and therapeutic strategies. Cureus. 2025;17(11):e98103. doi: 10.7759/cureus.98103.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 The copyright to the submitted manuscript is held by the Author, who grants the Journal of Face Aesthetics (JoFA) a nonexclusive licence to use, reproduce, and distribute the work, including for commercial purposes.
This work is licensed under a Creative Commons Attribution 4.0 International License.
